Earnings Preview: Oscar Health, Inc. (OSCR) Q2 Earnings Expected to Decline
Oscar Health (OSCR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
OSCR vs. CLOV: Which Stock Is A Better Buy Now?
In this piece, we'll check in on two mid-cap health insurance plays that are leveraging their tech-savvy and digital strengths to grab a bigger slice of the health insurance industry.
Why Oscar Health, Inc. (OSCR) Outpaced the Stock Market Today
Oscar Health, Inc. (OSCR) concluded the recent trading session at $14.45, signifying a +1.76% move from its prior day's close.
Oscar Health, Inc. (OSCR) Stock Declines While Market Improves: Some Information for Investors
In the most recent trading session, Oscar Health, Inc. (OSCR) closed at $14.2, indicating a -10.52% shift from the previous trading day.
Is $20 a Fair Valuation for Oscar Health (OSCR) — or a Stretch Too Far?
Key Points in This Article: Oscar Health's (OSCR) stock surged in June 2025 due to strong Q1 earnings but crashed after Centene's guidance withdrawal and analyst downgrades.
Oscar Health, Inc. (OSCR) Surpasses Market Returns: Some Facts Worth Knowing
Oscar Health, Inc. (OSCR) closed at $15.35 in the latest trading session, marking a +2.88% move from the prior day.
Oscar Health, Inc. (OSCR) Stock Slides as Market Rises: Facts to Know Before You Trade
Oscar Health, Inc. (OSCR) closed at $15.53 in the latest trading session, marking a -3.42% move from the prior day.
Why Oscar Health, Inc. (OSCR) Dipped More Than Broader Market Today
In the latest trading session, Oscar Health, Inc. (OSCR) closed at $16.55, marking a -1.55% move from the previous day.
Why I'm Buying Oscar's Panic Dip
Centene's $1.8B ACA risk shock triggered a ~15-20% drop in Oscar's stock but didn't alter Q1 fundamentals. Oscar posted 42% revenue growth, expanding to 2 million members with a record-low 15.8% SG&A expense ratio. Barclays' downgrade highlights policy risk, projecting over 100bps MLR pressure and aggressive EPS cuts if subsidies expire.
Oscar Health: Should You Buy OSCR Stock At $17?
On July 2nd, the health insurance sector underwent a notable decline following Centene (NYSE:CNC)'s retraction of its financial outlook, citing rising costs. Refer to – Centene: Is The Recent Decline In CNC Stock Justified?
Oscar Health, Inc. (OSCR) Stock Sinks As Market Gains: Here's Why
Oscar Health, Inc. (OSCR) concluded the recent trading session at $16.62, signifying a -18.73% move from its prior day's close.
Oscar Health, Inc. (OSCR) Declines More Than Market: Some Information for Investors
Oscar Health, Inc. (OSCR) closed the most recent trading day at $20.45, moving 4.62% from the previous trading session.
